Key result
Stem cell-based therapy is a promising strategy for ischemic heart diseases, though efficacy varies significantly across trials depending on cell types, sources, delivery methods, and doses.
Why the study?
Does stem cell therapy improve outcomes in patients with ischemic heart diseases?
Does stem cell therapy improve outcomes in patients with ischemic heart diseases?
Stem cell therapy and stem cell-derived exosomes represent promising but currently variable therapeutic strategies for myocardial repair and regeneration in ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for stem cell therapy in ischemic heart disease; standardization of protocols needed before clinical translation.
Yu et al. (2017) conducted a review in Ischemic heart diseases. Stem cell therapy was evaluated. Stem cell-based therapy is a promising strategy for ischemic heart diseases, though efficacy varies significantly across trials depending on cell types, sources, delivery methods, and doses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: